Conference abstract · 6 Oct 2025
Conference abstractPublished 6 Dec 2011
Management of infertile women suffering from polycystic ovarian syndrome
AKM Medical College, Bangladesh
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder aff ecting 4% to 8% of reproductive aged women. About 20% cause of female infertility is anovulation and 85% to 90% of those have PCOS. Th ere is a well established association between PCOS, insulin resistance, hyperinsulinaemia, hyperandrogenism and anovulation. Insulin resistance is a pivotal defect in PCOS and that metabolic abnormality leads to a compensatory increase in circulating insulin and this elevated insulin directly stimulates the ovary to produce excess androgens causing anovulation. As the underlying pathology is being unraveled better management strategies mostly remained symptomatic. For infertility resumption of ovulation by dieting, exercise and ovulation inducing agent remains the cornerstone of treatment. Clomiphene citrate (CC) is the 1st line of treatment resulting 75% to 80% ovulation. Others are called CC resistant who needs insulin sensitizer (Metformin) corticosteroids to combat hyperinsulinaemia and hyperandrogenism. Aromatase inhibitors ( Letrozole) are antioestrogenic agents with much shorter half life is superior in some cases to CC as it has got no negative eff ect on endometrium. In our studies we found satisfactory results by using letrozole, metformin and glucocorticoids. Low dose gonadotropins in step up protocol much eff ective than other ovulation inducing agents but needs meticulous judgment and monitoring. In our study we found better result by using combination of drugs. Laparoscopic ovarian drilling can be restricted for those patients who failed to ovulate by combination of drugs or during assessment of tubal factor. Finally if all eff orts failed to make the patient ovulatory controlled ovarian hyperstimulation and In-vitro fertilization (IVF) is the treatment of choice. Fine tuning is necessary for induction of ovulation in PCOS patients by individualized regimens to get the optimum result.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Rashida Begum”
